Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
37.88B | 35.17B | 31.76B | 31.41B | 28.69B | Gross Profit |
24.55B | 22.28B | 20.53B | 21.38B | 19.13B | EBIT |
13.40B | 12.70B | 12.54B | 13.08B | 11.72B | EBITDA |
15.75B | 13.37B | 13.79B | 14.17B | 12.92B | Net Income Common Stockholders |
7.06B | 7.79B | 9.05B | 9.11B | 8.06B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
4.22B | 3.06B | 3.21B | 4.50B | 7.28B | Total Assets |
61.78B | 65.30B | 61.68B | 41.29B | 44.81B | Total Debt |
45.70B | 47.91B | 43.12B | 27.81B | 31.54B | Net Debt |
41.48B | 44.85B | 39.92B | 23.31B | 24.26B | Total Liabilities |
71.65B | 74.75B | 67.99B | 49.50B | 55.45B | Stockholders Equity |
-11.75B | -11.22B | -8.96B | -10.11B | -12.57B |
Cash Flow | Free Cash Flow | |||
10.77B | 7.88B | 9.73B | 11.22B | 9.21B | Operating Cash Flow |
12.22B | 9.20B | 10.80B | 11.97B | 9.81B | Investing Cash Flow |
-1.09B | -3.60B | -15.68B | -2.36B | -1.15B | Financing Cash Flow |
-9.48B | -5.58B | 6.16B | -11.98B | -8.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $270.96B | 35.59 | -37142.11% | 3.07% | 6.83% | -4.85% | |
73 Outperform | $101.88B | 10.02 | -503.31% | 6.68% | -1.03% | 25.20% | |
70 Outperform | $1.45B | 11.70 | 8.79% | 5.51% | 12.88% | -5.64% | |
64 Neutral | $8.87B | 14.81 | 5.05% | 174.26% | 3.56% | 3.68% | |
64 Neutral | $2.24B | 29.90 | 3.49% | 0.43% | 106.83% | 10.27% | |
61 Neutral | $96.48B | 25.05 | 5.87% | 6.60% | -2.51% | ― | |
58 Neutral | $1.15B | 30.50 | 27.53% | 0.44% | 3.17% | -2.23% |
On May 7, 2025, Philip Morris International Inc. held its 2025 Virtual Annual Meeting of Shareholders, where Chairman André Calantzopoulos and CEO Jacek Olczak discussed the company’s excellent performance in 2024 and a strong start to 2025. They highlighted PMI’s achievements in its smoke-free journey, including reaching $15 billion in net revenues from smoke-free products, and the company’s commitment to sustainable growth and shareholder returns. The meeting also saw the election of 11 directors and the approval of executive compensation and auditors. PMI continues to advance its multicategory strategy with leading brands like IQOS, ZYN, and VEEV, reinforcing its position as a global smoke-free champion.
Spark’s Take on PM Stock
According to Spark, TipRanks’ AI Analyst, PM is a Outperform.
Philip Morris holds a strong position with robust profit margins and cash flow generation. The positive momentum in technical indicators and strategic focus on smoke-free products further bolster its outlook. However, high leverage and valuation concerns temper the score, requiring cautious optimism.
To see Spark’s full report on PM stock, click here.
On February 19, 2025, PMI’s CEO Jacek Olczak and CFO Emmanuel Babeau addressed investors at the Consumer Analyst Group of New York Conference, emphasizing the company’s transition towards smoke-free products. The presentation highlighted PMI’s strategic focus on delivering superior returns to shareholders, expanding its presence in smoke-free markets, and achieving significant growth in smoke-free net revenues, aiming for $15 billion and entering over 100 markets by 2024. While PMI has faced challenges such as regulatory restrictions and economic uncertainties, the company remains optimistic about its future growth and industry positioning through continued innovation and market expansion.
On February 19, 2025, Philip Morris International reaffirmed its full-year forecast at the Consumer Analyst Group of New York Conference, projecting an adjusted diluted EPS growth of 7.2% to 9.1% compared to 2024. PMI highlighted its decade-long progress towards smoke-free products and shared strategies for delivering superior shareholder returns, signaling strong industry positioning and a commitment to innovation.